MYC Emerges as a Key Therapeutic Target in Melanoma
A new Frontiers review positions the transcription factor MYC as a convergent, functionally critical target in melanoma, surveying new strategies to drug a long-'undruggable' oncogene.
Topic
Topic
A new Frontiers review positions the transcription factor MYC as a convergent, functionally critical target in melanoma, surveying new strategies to drug a long-'undruggable' oncogene.